AR104110A1 - Composiciones y métodos para detectar un contaminante biológico - Google Patents

Composiciones y métodos para detectar un contaminante biológico

Info

Publication number
AR104110A1
AR104110A1 ARP160100814A ARP160100814A AR104110A1 AR 104110 A1 AR104110 A1 AR 104110A1 AR P160100814 A ARP160100814 A AR P160100814A AR P160100814 A ARP160100814 A AR P160100814A AR 104110 A1 AR104110 A1 AR 104110A1
Authority
AR
Argentina
Prior art keywords
specific
oligonucleotide
detection probe
artificial
oligonucleotide primer
Prior art date
Application number
ARP160100814A
Other languages
English (en)
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56297073&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR104110(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of AR104110A1 publication Critical patent/AR104110A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/166Oligonucleotides used as internal standards, controls or normalisation probes

Abstract

Se proveen composiciones y métodos útiles para la determinación de si un contaminante microbiano está presente en un proceso de producción de agentes terapéuticos biológicos. Específicamente, se proveen un plásmido control de amplificación positivo artificial y una sonda de detección de PCR cuantitativa única, lo cual posibilita la detección rápida y en tiempo real de un resultado falso positivo. Reivindicación 1: Una composición que comprende una secuencia nucleotídica artificial, un fluoróforo, y un desactivador, donde la secuencia nucleotídica artificial comprende en su extremo 3 no más de cinco ácidos nucleicos consecutivos que son idénticos a una secuencia de cualquiera de SEC ID Nº 9 y 12 - 37. Reivindicación 9: Una composición que comprende: a) un cebador oligonucleotídico delantero especifico para parvovirus de roedor; b) una sonda de detección de oligonucleótidos específica para parvovirus de roedor; c) una sonda de detección de oligonucleótidos artificial; d) un cebador oligonucleotídico inverso específico para un parvovirus de roedor; e) un cebador oligonucleotídico delantero específico para M13; f) una sonda de detección de oligonucleótidos específica para M13; y g) un cebador oligonucleotídico inverso específico para M13.
ARP160100814A 2015-03-27 2016-03-28 Composiciones y métodos para detectar un contaminante biológico AR104110A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562139321P 2015-03-27 2015-03-27

Publications (1)

Publication Number Publication Date
AR104110A1 true AR104110A1 (es) 2017-06-28

Family

ID=56297073

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP160100814A AR104110A1 (es) 2015-03-27 2016-03-28 Composiciones y métodos para detectar un contaminante biológico
ARP200102452A AR119878A2 (es) 2015-03-27 2020-09-01 Composiciones y métodos para detectar un contaminante biológico

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP200102452A AR119878A2 (es) 2015-03-27 2020-09-01 Composiciones y métodos para detectar un contaminante biológico

Country Status (19)

Country Link
US (3) US10669594B2 (es)
EP (3) EP3699298B1 (es)
JP (4) JP6670847B2 (es)
CN (2) CN107960108B (es)
AR (2) AR104110A1 (es)
AU (2) AU2016243498B2 (es)
BR (1) BR112017020582A2 (es)
CA (2) CA3226784A1 (es)
DK (1) DK3274469T3 (es)
EA (2) EA202190319A1 (es)
ES (1) ES2804845T3 (es)
IL (4) IL302434A (es)
MX (2) MX2017012437A (es)
PL (1) PL3274469T3 (es)
PT (1) PT3274469T (es)
SG (2) SG10202006108RA (es)
TW (3) TWI735433B (es)
WO (1) WO2016160572A1 (es)
ZA (2) ZA201706797B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI735433B (zh) 2015-03-27 2021-08-11 美商再生元醫藥公司 偵測生物污染物之組成物及方法
EP3638697A4 (en) 2017-06-12 2021-07-07 Bluefin Biomedicine, Inc. ANTI-IL1RAP ANTIBODIES AND ANTIBODY INGREDIENT CONJUGATES
US20190093149A1 (en) * 2017-09-27 2019-03-28 The United States Of America, As Represented By The Secretary Of Agriculture Assays for detecting multiple tick-borne pathogens
CN112105747A (zh) * 2018-01-30 2020-12-18 拜奥法尔防护有限责任公司 用于验证核酸扩增测定的方法和系统
TW201945732A (zh) * 2018-03-20 2019-12-01 美商路瑪賽特有限責任公司 使用雷射力細胞學之先進生理及生化細胞監測與定量
US11702653B2 (en) 2018-05-21 2023-07-18 Battelle Memorial Institute Control compositions and methods for sequencing
EP3894553A4 (en) * 2018-12-13 2022-06-29 Battelle Memorial Institute Methods and control compositions for a quantitative polymerase chain reaction
KR102278112B1 (ko) * 2020-07-10 2021-07-15 (주)하임바이오텍 특정 인공 뉴클레오타이드 서열을 이용한 위양성 판단용 조성물 및 이를 이용한 위양성 판단 방법
WO2022133005A1 (en) * 2020-12-17 2022-06-23 Amgen Inc. Real time pcr method to detect bovine parvovirus 3
KR20230011040A (ko) * 2021-07-13 2023-01-20 재단법인 바이오나노헬스가드연구단 미생물 현장 오염 검출용 조성물 및 이의 용도
CN114561492A (zh) * 2022-02-28 2022-05-31 宁夏回族自治区疾病预防控制中心(宁夏回族自治区性病艾滋病防治中心) 一种新冠病毒核酸检测阳性质控品及其制备方法和用途
CN116814848B (zh) * 2023-04-12 2024-03-19 中国医学科学院医学实验动物研究所 基于荧光raa检测小鼠微小病毒的引物和探针及方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5585254A (en) * 1987-08-21 1996-12-17 University Of Colorado Foundation, Inc. Autonomous parvovirus gene delivery vehicles and expression vectors
US5371241A (en) 1991-07-19 1994-12-06 Pharmacia P-L Biochemicals Inc. Fluorescein labelled phosphoramidites
US7087411B2 (en) 1999-06-08 2006-08-08 Regeneron Pharmaceuticals, Inc. Fusion protein capable of binding VEGF
ES2343394T3 (es) * 1999-08-13 2010-07-29 Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts Variantes de ns1 de parvovirus.
AT409383B (de) * 1999-12-22 2002-07-25 Baxter Ag Verfahren zur detektion und quantifizierung von nukleinsäuren in einer probe
US20020177222A1 (en) * 2000-08-10 2002-11-28 Sikun Li Replication competent AAV helper functions
BRPI0211191B8 (pt) * 2001-06-28 2021-07-27 Chiron Corp ensaios baseados em ácido nucléico para se diagnosticar precisamente infecção por parvovírus b19 e inciadores e marcadores para uso nesses ensaios
DE60309238T2 (de) 2002-03-08 2007-06-06 Asml Netherlands B.V. Lithographische Maske, lithographischer Apparat und Verfahren zur Herstellung einer Vorrichtung
WO2004044247A2 (en) 2002-11-12 2004-05-27 Genolife One step real-time rt pcr kits for the universal detection of organisms in industrial products
JP4805158B2 (ja) * 2003-05-16 2011-11-02 アメリカ合衆国 核酸増幅系に用いる内部コントロール核酸分子
DE102006034844B3 (de) * 2006-07-27 2007-12-06 DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH Zusammensetzungen und Verfahren zur Amplifikation von Hepatitis A-Viren (HAV) und/oder Parvoviren B19 (PB19) mittels Multiplex-PCR
US7771997B2 (en) 2007-06-04 2010-08-10 Regeneron Pharmaceuticals, Inc. Enhanced expression and stability regions
EP2098599A1 (en) * 2008-03-05 2009-09-09 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Composition comprising an oligonucleotide mixture for the detection of contaminations in cell cultures
WO2010111509A1 (en) * 2009-03-25 2010-09-30 Life Technologies Corporation Discriminatory positive/extraction control dna
WO2010151792A1 (en) 2009-06-26 2010-12-29 Regeneron Pharmaceuticals, Inc. Readily isolated bispecific antibodies with native immunoglobulin format
WO2012052158A2 (en) * 2010-10-21 2012-04-26 Deutsches Krebsforschungszentrum Retargeting of rat parvovirus h-1pv to cancer cells through genetic engineering of its capsid
US9580761B2 (en) * 2011-02-25 2017-02-28 Novartis Ag Exogenous internal positive control
CN102206713B (zh) * 2011-04-06 2013-01-02 浙江大学 三重荧光定量rt-pcr检测试剂盒及用途
GB201203568D0 (en) * 2012-02-29 2012-04-11 Vela Operations Pte Ltd Real time PCR detection of streptococcus
HU230463B1 (hu) * 2012-07-02 2016-07-28 Ud-Genomed Medical Genomic Technologies Kft. Kontroll rendszer immunprecipitációs vizsgálatokhoz
WO2014055515A1 (en) * 2012-10-02 2014-04-10 Neurophage Pharmaceuticals, Inc. Use of p3 of bacteriophage fusion proteins as amyloid binding agents
GB2525024A (en) * 2014-04-10 2015-10-14 Vela Operations Pte Ltd Universal controls for sequencing assays
TWI735433B (zh) 2015-03-27 2021-08-11 美商再生元醫藥公司 偵測生物污染物之組成物及方法

Also Published As

Publication number Publication date
ZA201806101B (en) 2020-12-23
US20160281182A1 (en) 2016-09-29
CA2980915C (en) 2024-02-27
CA3226784A1 (en) 2016-10-06
EP3699298B1 (en) 2024-04-24
AU2016243498A1 (en) 2017-10-26
PL3274469T3 (pl) 2020-10-05
EA201792155A1 (ru) 2018-04-30
TW201706413A (zh) 2017-02-16
JP2023184743A (ja) 2023-12-28
CN107960108A (zh) 2018-04-24
AU2022246398A1 (en) 2022-11-03
AR119878A2 (es) 2022-01-19
TWI804917B (zh) 2023-06-11
ZA201706797B (en) 2020-01-29
US20200248278A1 (en) 2020-08-06
CN107960108B (zh) 2022-03-08
WO2016160572A1 (en) 2016-10-06
EP3274469A1 (en) 2018-01-31
JP2020103306A (ja) 2020-07-09
AU2016243498A2 (en) 2018-04-19
IL254731A0 (en) 2017-11-30
US20230295747A1 (en) 2023-09-21
JP7385623B2 (ja) 2023-11-22
IL302434A (en) 2023-06-01
MX2017012437A (es) 2018-06-19
JP6894026B2 (ja) 2021-06-23
SG11201707690QA (en) 2017-10-30
EP4361290A2 (en) 2024-05-01
MX2021007667A (es) 2021-08-05
IL281579B (en) 2022-02-01
PT3274469T (pt) 2020-05-29
BR112017020582A2 (pt) 2018-07-17
EP3274469B1 (en) 2020-04-29
IL281579A (en) 2021-05-31
TW202336236A (zh) 2023-09-16
EA037740B1 (ru) 2021-05-17
KR20180026661A (ko) 2018-03-13
CA2980915A1 (en) 2016-10-06
DK3274469T3 (da) 2020-06-15
JP6670847B2 (ja) 2020-03-25
TWI735433B (zh) 2021-08-11
EA202190319A1 (ru) 2021-09-30
CN114875175A (zh) 2022-08-09
AU2016243498B2 (en) 2022-07-07
TW202140801A (zh) 2021-11-01
EP3699298A1 (en) 2020-08-26
US10669594B2 (en) 2020-06-02
JP2021121226A (ja) 2021-08-26
US11549154B2 (en) 2023-01-10
JP2018509174A (ja) 2018-04-05
SG10202006108RA (en) 2020-08-28
ES2804845T3 (es) 2021-02-09
IL289447A (en) 2022-02-01
IL254731B (en) 2021-04-29

Similar Documents

Publication Publication Date Title
AR104110A1 (es) Composiciones y métodos para detectar un contaminante biológico
Tosetti et al. Amoebae as a tool to isolate new bacterial species, to discover new virulence factors and to study the host–pathogen interactions
BR112012030813A2 (pt) "métodos e kits para detecção in situ de sequências de nucleotídeo"
MX2018014163A (es) Composiciones de nucleotido marcados y metodos para el secuenciamiento de acido nucleico.
MX2021008867A (es) Composiciones reactantes marcadas de intensidad alta y metodos de secuenciamiento.
Chan et al. A novel loop-mediated isothermal amplification approach for sex identification of Columbidae birds
RU2013153505A (ru) Способы, системы и композиции для детекции микробной днк при помощи пцр
EP4296373A3 (en) Normalization controls for managing low sample inputs in next generation sequencing
ES2722900T3 (es) Portaobjetos para micromatrices y método para detectar algas tóxicas
AR105439A1 (es) Procedimientos de purificación de un virus producido in vitro y ensayo de eliminación del virus
Koiwai et al. Rapid diagnosis of three shrimp RNA viruses using RT-PCR-DNA chromatography
ATE357539T1 (de) Nukleinsäuresonden und breite primerbereiche aus topoisomerasegenbereichen und verfahren mit deren anwendung
WO2016051177A3 (en) Methods and kits
ATE514794T1 (de) Zusammensetzungen und verfahren für den nachweis von enterokokken-nukleinsäuren
DE602004019059D1 (de) Methode zur linearen nicht-selektiven amplifikation von nukleinsäuren
CL2016000299A1 (es) Metodo para la deteccion de resistencia a piretroides en crustaceos usando secuencias oligonucleotidas utiles en la deteccion de resistencia a piretroide.
AR109017A1 (es) Métodos para utilizar polinucleótidos largos de adn simple cadena como cebadores (primers) en ensayos de pcr
EP4249610A3 (en) Methods and compositions for detecting candida species
PL421586A1 (pl) Sposoby wykrywania mutacji germinalnych w obrębie 13. i 17. chromosomu człowieka oznaczanych jako: c.5744C>T, c.181T>G, c.4035delA, c.190T>C i c.3700_3704delGTAAA oraz zestawy diagnostyczne sporządzane na ich podstawie
JP2007135499A (ja) サルモネラo9群の検出法
WO2021050393A3 (en) Targeted sequencing to detect and quantify low levels of methylated dna
UA117099U (uk) Спосіб індикації днк бактерії chlamydia suis у полімеразній ланцюговій реакції шляхом ампліфікації фрагмента гена головного білка мембрани (момp) для її видової диференціації
MY175723A (en) Oligonucleotides and a method for detecting and/or quantifying human metapneumovirus (hmpv)
MY192219A (en) A novel method for deterction of salmonella typhi
PL431942A1 (pl) Sposób i zestaw do wykrywania pozajelitowych szczepów E. coli patogennych dla drobiu